See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516551_2023_Skye_Bioscience_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001516551, Skye Bioscience Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 8,943,718 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 87,854 |
| 3 | remainder_Assets | 79,500 |
| 4 | LiabilitiesCurrent | 12,119,126 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,094,617 |
| 9 | ResearchAndDevelopmentExpense | 6,011,805 |
| 10 | remainder_Expenses | 6,212,051 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,163,129 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 9,111,072 |
| 1 | Liabilities | 12,119,126 |
| 2 | Expenses | 18,318,473 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -3,008,054 |
| 5 | NetIncome | -19,481,602 |
| 6 | ComprehensiveNetIncome | -19,481,602 |
| 7 | BaseVar | 20,355,900 |
| 8 | EconomicCapitalRatio | -2.32 |
Edgar->Model Mapping
Feature Distribution
Change over Time
